MA27960A1 - Melanges lipidiques synthetiques ameliores pour la preparation d'un tensioactif reconstitue. - Google Patents

Melanges lipidiques synthetiques ameliores pour la preparation d'un tensioactif reconstitue.

Info

Publication number
MA27960A1
MA27960A1 MA27946A MA27946A MA27960A1 MA 27960 A1 MA27960 A1 MA 27960A1 MA 27946 A MA27946 A MA 27946A MA 27946 A MA27946 A MA 27946A MA 27960 A1 MA27960 A1 MA 27960A1
Authority
MA
Morocco
Prior art keywords
preparation
synthetic lipid
lipid mixtures
improved synthetic
reconstituted surfactant
Prior art date
Application number
MA27946A
Other languages
English (en)
French (fr)
Inventor
Tore Curstedt
Jan Johansson
Bengt Robertson
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of MA27960A1 publication Critical patent/MA27960A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/785Alveolar surfactant peptides; Pulmonary surfactant peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MA27946A 2002-05-17 2004-11-16 Melanges lipidiques synthetiques ameliores pour la preparation d'un tensioactif reconstitue. MA27960A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2002MI001058A ITMI20021058A1 (it) 2002-05-17 2002-05-17 Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito

Publications (1)

Publication Number Publication Date
MA27960A1 true MA27960A1 (fr) 2006-07-03

Family

ID=11449919

Family Applications (1)

Application Number Title Priority Date Filing Date
MA27946A MA27960A1 (fr) 2002-05-17 2004-11-16 Melanges lipidiques synthetiques ameliores pour la preparation d'un tensioactif reconstitue.

Country Status (26)

Country Link
US (2) US7511011B2 (enExample)
EP (1) EP1506234B1 (enExample)
JP (1) JP4883906B2 (enExample)
KR (1) KR101028927B1 (enExample)
CN (1) CN100347193C (enExample)
AT (1) ATE353919T1 (enExample)
AU (1) AU2003233320B2 (enExample)
CA (1) CA2486152C (enExample)
CY (1) CY1106667T1 (enExample)
DE (1) DE60311798T2 (enExample)
DK (1) DK1506234T3 (enExample)
EA (1) EA007928B1 (enExample)
ES (1) ES2282627T3 (enExample)
HR (1) HRP20041058B1 (enExample)
IL (2) IL165239A0 (enExample)
IT (1) ITMI20021058A1 (enExample)
MA (1) MA27960A1 (enExample)
MX (1) MXPA04011369A (enExample)
NZ (1) NZ536606A (enExample)
PL (1) PL209649B1 (enExample)
PT (1) PT1506234E (enExample)
SI (1) SI1506234T1 (enExample)
TN (1) TNSN04219A1 (enExample)
UA (1) UA79609C2 (enExample)
WO (1) WO2003097695A1 (enExample)
ZA (1) ZA200409215B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
ATE413178T1 (de) 2003-03-24 2008-11-15 Actimis Pharmaceuticals Inc 2-phenoxy- und 2-phenylsulfanyl-benzenesulfonamid derivate mit ccr3 antagonistischer aktivität zur behandlung von asthma und anderen entzündlichen oder immunologischen erkrankungen
EP1481665A1 (en) * 2003-05-30 2004-12-01 CHIESI FARMACEUTICI S.p.A. Novel lipid mixtures for synthetic surfactants
UA76074C2 (en) * 2005-11-09 2006-06-15 O V Palladin Inst Of Biochemis Calmophil, pharmaceutical composition for substitution therapy aimed at recovering malfunctioned surfactant system of lungs
BRPI0715317B1 (pt) 2006-10-13 2021-10-05 Chiesi Farmaceutici S.P.A. Surfactantes reconstituídos com propriedades aperfeiçoadas
EP2142196A4 (en) 2007-03-29 2010-06-30 Nat Jewish Health SURFACTANTLIPIDS, COMPOSITIONS AND THEIR USE
EP1997502A1 (en) * 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) * 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides
US8287887B2 (en) 2008-04-02 2012-10-16 The University Of Tokushima Antigen-and-drug vehicle comprising synthetic peptide, and mucosal vaccine using the same
US8399406B2 (en) * 2009-06-05 2013-03-19 Chiesi Farmaceutici S.P.A. Reconstituted surfactant composition containing analogs of surfactant protein B (SP-B) and surfactant protein C (SP-C)
EP2611418A2 (en) * 2010-08-30 2013-07-10 F.Hoffmann-La Roche Ag Tetranectin-apolipoprotein a-1, lipid particles containing it and its use
BR112013033562A2 (pt) 2011-08-25 2017-02-14 Hoffmann La Roche proteína de fusão de tetranectina-apolipoproteína a-i encurtada, uma partícula de lipídio que a contém e uso das mesmas
BR112015009486B1 (pt) 2012-11-21 2022-06-14 Chiesi Farmaceutici S.P.A Surfactante reconstituído, formulação farmacêutica, kit e uso de surfactante reconstituído

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0706374B1 (en) * 1993-06-30 1997-12-10 Genentech, Inc. Method for preparing liposomes
AU2322097A (en) * 1996-03-27 1997-10-17 Ortho Pharmaceutical Corporation Lyophilized pulmonary surfactant peptide compositions
IT1308180B1 (it) * 1999-02-12 2001-12-07 Chiesi Farma Spa Peptidi sintetici aventi la capacita' di diminuire la tensionesuperficiale e loro impiego nella preparazione di un surfattante
AU2001245848A1 (en) * 2000-03-15 2001-10-23 Advanced Research And Technology Institute Oral tolerance induction by collagen to prevent allograft rejection
CA2405811C (en) * 2000-04-12 2011-09-27 Altana Pharma Ag Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
ITMI20021058A1 (it) * 2002-05-17 2003-11-17 Chiesi Farma Spa Miscele di lipidi sintetici ottimizzate per la preparazione di un surfattante ricostituito
EP1997502A1 (en) 2007-06-01 2008-12-03 CHIESI FARMACEUTICI S.p.A. Reconstituted surfactants having improved properties
EP2022798A1 (en) 2007-08-09 2009-02-11 CHIESI FARMACEUTICI S.p.A. Synthetic pulmonary surfactant peptides

Also Published As

Publication number Publication date
US7511011B2 (en) 2009-03-31
EP1506234A1 (en) 2005-02-16
EA007928B1 (ru) 2007-02-27
PL372751A1 (en) 2005-08-08
ES2282627T3 (es) 2007-10-16
MXPA04011369A (es) 2005-02-17
DE60311798D1 (de) 2007-03-29
EP1506234B1 (en) 2007-02-14
DK1506234T3 (da) 2007-06-11
AU2003233320B2 (en) 2008-06-19
US7842664B2 (en) 2010-11-30
HRP20041058A2 (en) 2005-02-28
CA2486152C (en) 2012-09-11
ZA200409215B (en) 2006-02-22
TNSN04219A1 (en) 2007-03-12
IL165239A0 (en) 2005-12-18
WO2003097695A1 (en) 2003-11-27
US20050176625A1 (en) 2005-08-11
ITMI20021058A1 (it) 2003-11-17
ITMI20021058A0 (it) 2002-05-17
EA200401385A1 (ru) 2005-08-25
NZ536606A (en) 2006-10-27
UA79609C2 (en) 2007-07-10
AU2003233320A2 (en) 2003-12-02
HRP20041058B1 (hr) 2013-11-22
KR101028927B1 (ko) 2011-04-12
SI1506234T1 (sl) 2007-06-30
IL165239A (en) 2012-10-31
CN1653088A (zh) 2005-08-10
PT1506234E (pt) 2007-05-31
AU2003233320A1 (en) 2003-12-02
CY1106667T1 (el) 2012-05-23
CA2486152A1 (en) 2003-11-27
DE60311798T2 (de) 2007-10-31
HK1079221A1 (zh) 2006-03-31
PL209649B1 (pl) 2011-09-30
ATE353919T1 (de) 2007-03-15
JP2006504635A (ja) 2006-02-09
CN100347193C (zh) 2007-11-07
KR20050016408A (ko) 2005-02-21
JP4883906B2 (ja) 2012-02-22
US20080242589A1 (en) 2008-10-02

Similar Documents

Publication Publication Date Title
MA27960A1 (fr) Melanges lipidiques synthetiques ameliores pour la preparation d'un tensioactif reconstitue.
Qanbar et al. Role of the palmitoylation of surfactant-associated protein C in surfactant film formation and stability
WO2002080860A3 (en) Methods, compounds, and compositions for reducing body fat and modulating fatty acid metabolism
CL2004001551A1 (es) Formula para infantes o de continuacion, que comprende una fuente de proteinas, lipidos, carbohidratos y un probiotico, donde al menos 40% de las proteinas son proteinas de suero dulce modificadas que comprenden una cantidad reducida de cgmp o no con
EP1490483A4 (en) IN VIVO INSTALLATION OF NON-NATURAL AMINO ACIDS
DK0590006T3 (da) Syntetiske pulmonære surfaktantpeptider
AR037909A1 (es) Composiciones de formulaciones para lactantes que comprenden cantidades incrementadas de alfa-lactalbumina
ATE486499T1 (de) Angereicherte säuglingsanfangsnahrung
DE69822176D1 (de) Peptid/lipid-komplexbildung durch co-lyophilisation
DK1228708T4 (da) Mælkeafledt basisk proteinfraktion som middel til formindskelse af höjt blodtryk
ATE381578T1 (de) Peptide, basierend auf der sequenz des menschlichen lactoferrins und ihre anwendung
BR0309421A (pt) Composições de proteìna associada com corpo oleoso e métodos de uso destas para reduzir o risco de doença cardiovascular
ATE253927T1 (de) Wirkstoff für verbesserten fettstoffwechsel
DE602004005821D1 (de) Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis
NO993407L (no) Fremstilling av proteinpreparater med nedsatt aggregatinnhold
EA200501684A1 (ru) Новые липидные смеси для синтетических сурфактантов
EP0515246A3 (fr) Compositions protéiques à textures onctueuse
DE69835609D1 (de) L-valine für lebererkrankungen
UY26358A1 (es) Composición que comprende proteína de caseina y proteína de suero
KR970074792A (ko) 합성 펩타이드를 이용한 폐 계면활성제
川村欣也 Enhanced hepatic lipid peroxidation in patients with primary biliary cirrhosis
MA27419A1 (fr) Appareil de vente de glace vanillee avec gaufrette
JPH0728459U (ja) 足乗せ台
CU22479A1 (es) Surfactante pulmonar natural porcino